Semler Scientific, a medical technology company with substantial holdings of Bitcoin, has reached a $29.75 million settlement with the U.S. Department of Justice (DOJ) to resolve allegations of violating federal anti-fraud statutes related to its flagship product, QuantaFlo. This agreement follows years of investigation by the DOJ, which began in 2017 after sending a civil investigative demand. The case has seen an extended period with Semler facing further subpoenas and eventually entering settlement discussions with the DOJ in February 2025. Semler will utilize its Bitcoin holdings as collateral to settle this case, leveraging a loan from Coinbase for this purpose, and is currently exploring raising funds through securities. This move aims to purchase more Bitcoin and strengthen the company’s crypto portfolio while minimizing financial strain.